Register      Login
Journal of Primary Health Care Journal of Primary Health Care Society
Journal of The Royal New Zealand College of General Practitioners
RESEARCH ARTICLE (Open Access)

What is the best oral treatment for those nasty looking toes?

Vanessa Jordan
+ Author Affiliations
- Author Affiliations

1 New Zealand Cochrane Fellow, University of Auckland, Auckland, New Zealand

Correspondence to: Vanessa Jordan. Email: v.jordan@auckland.ac.nz

Journal of Primary Health Care 9(4) 328-328 https://doi.org/10.1071/HC15927
Published: 20 December 2017

Journal Compilation © Royal New Zealand College of General Practitioners 2017.
This is an open access article licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

COCHRANE REVIEW: Kreijkamp-Kaspers S, Hawke K, Guo L, Kerin G, Bell-Syer SEM, Magin P, Bell-Syer SV, van Driel ML. Oral antifungal medication for toenail onychomycosis. Cochrane Database of Systematic Reviews 2017, Issue 7.

THE PROBLEM: Onychomycosis is a fungal infection of the nail. It is a common condition that accounts for 50% of all nail diseases. It has a worldwide prevalence of 2–8%.1 Onychomycosis is more likely to affect older adults, people with diabetes, people with psoriasis and people who are immunosuppressed.1 Griseofulvin was the first oral antifungal agent used to treat this condition2 with the azole group of medications coming next, followed by terbinafine.2

CLINICAL BOTTOM LINE: This Cochrane review showed that terbinafine was the most effective treatment for achieving a normal looking nail. Azole was also an effective treatment as was griseofulvin. Griseofulvin however, was more likely to cause greater incidence of adverse effects and was not as effective as terbinafine or azole.3



Click to zoom



References

[1]  Gupta AK, Versteeg SG, Shear NH. Onychomycosis in the 21st Century: An Update on Diagnosis, Epidemiology, and Treatment. J Cutan Med Surg 2017; June. 1203475417716362.

[2]  Gupta AK, Sauder DN, Shear NH. Antifungal agents: an overview. Part I. J Am Acad Dermatol. 1994; 30 677–698.
Antifungal agents: an overview. Part I.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2c3jtVOhsQ%3D%3D&md5=cbd442fce877caddb08daf175b16fd5fCAS |

[3]  Kreijkamp-Kaspers S, Hawke K, Guo L,, et al. Oral antifungal medication for toenail onychomycosis. Cochrane Database of Systematic Reviews. 2017; CD010031
Oral antifungal medication for toenail onychomycosis.Crossref | GoogleScholarGoogle Scholar |